• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Increased striatal dopamine transporter levels, as indicated by a DAT scan, induced by ziprasidone in association to improvement of tardive dyskinesia--a case report.

作者信息

Rizos E N, Chatziioannou S, Siafakas N, Douzenis A, Katsantoni E, Mandrapilia A, Bacalis S, Fotiadis C, Lykouras L

出版信息

Prog Neuropsychopharmacol Biol Psychiatry. 2010 Aug 16;34(6):1135-6. doi: 10.1016/j.pnpbp.2010.05.001. Epub 2010 May 10.

DOI:10.1016/j.pnpbp.2010.05.001
PMID:20460141
Abstract
摘要

相似文献

1
Increased striatal dopamine transporter levels, as indicated by a DAT scan, induced by ziprasidone in association to improvement of tardive dyskinesia--a case report.齐拉西酮诱导纹状体多巴胺转运体水平升高（由DAT扫描显示），与迟发性运动障碍改善相关——病例报告
Prog Neuropsychopharmacol Biol Psychiatry. 2010 Aug 16;34(6):1135-6. doi: 10.1016/j.pnpbp.2010.05.001. Epub 2010 May 10.
2
Signs of striatal dopamine transporter density increase in association with improvement of tardive dyskinesia in a patient with schizophrenia, as demonstrated by a DAT scan.一项多巴胺转运蛋白扫描（DAT 扫描）显示，精神分裂症患者的纹状体多巴胺转运体密度增加，与迟发性运动障碍改善相关。
Eur Neuropsychopharmacol. 2010 Feb;20(2):132-6. doi: 10.1016/j.euroneuro.2009.08.002. Epub 2009 Sep 8.
3
Dopamine transporter density in schizophrenic subjects with and without tardive dyskinesia.伴有和不伴有迟发性运动障碍的精神分裂症患者的多巴胺转运体密度
Schizophr Res. 2004 Dec 1;71(2-3):371-5. doi: 10.1016/j.schres.2004.03.015.
4
Ziprasidone induced tardive cervical dystonia.齐拉西酮诱发迟发性颈部肌张力障碍。
Psychopharmacol Bull. 2009;42(4):64-8.
5
Ziprasidone-associated pedal edema in the treatment of schizophrenia.
Prog Neuropsychopharmacol Biol Psychiatry. 2006 Jul;30(5):963-4. doi: 10.1016/j.pnpbp.2006.01.020. Epub 2006 Mar 6.
6
Combination of ziprasidone and clozapine in treatment-resistant schizophrenia.齐拉西酮与氯氮平联合治疗难治性精神分裂症
Hum Psychopharmacol. 2004 Jun;19(4):271-3. doi: 10.1002/hup.580.
7
Improvement in Pisa syndrome and tardive dyskinesia following aripiprazole treatment.
J Neuropsychiatry Clin Neurosci. 2009 Summer;21(3):350-1. doi: 10.1176/jnp.2009.21.3.350.
8
Ziprasidone outcome and tolerability: a practical clinical trial with plasma drug levels.齐拉西酮的疗效与耐受性：一项检测血药浓度的实用临床试验
Pharmacopsychiatry. 2007 May;40(3):89-92. doi: 10.1055/s-2007-973835.
9
Improvement of tardive dyskinesia with risperidone: a case report.
J Med Assoc Thai. 2000 Nov;83(11):1430-2.
10
Focus on ziprasidone.关注齐拉西酮。
Curr Med Res Opin. 2001;17(2):146-50.

引用本文的文献

1
Efficacy of Electroconvulsive Therapy for the Treatment of Movement Disorders: A Literature Review.电休克治疗对运动障碍的疗效：文献综述
Cureus. 2023 Mar 24;15(3):e36634. doi: 10.7759/cureus.36634. eCollection 2023 Mar.
2
Resveratrol Protects Against Vacuous Chewing Movements Induced by Chronic Treatment with Fluphenazine.白藜芦醇可预防慢性氟奋乃静治疗引起的空嚼运动。
Neurochem Res. 2017 Nov;42(11):3033-3040. doi: 10.1007/s11064-017-2335-4. Epub 2017 Jul 25.
3
Tardive dyskinesia in patients treated with atypical antipsychotics: case series and brief review of etiologic and treatment considerations.
接受非典型抗精神病药物治疗患者的迟发性运动障碍：病例系列及病因与治疗考量简述
Drugs Context. 2014 Apr 9;3:212259. doi: 10.7573/dic.212259. eCollection 2014.
4
ECT in a patient with Parkinson's disease and schizophrenia, with dopamine transporter visualisation using 123I-ioflupane SPET.使用 123I-碘代托烷 SPET 对伴有精神分裂症的帕金森病患者进行 ECT，并对多巴胺转运体进行可视化。
J Neural Transm (Vienna). 2011 Apr;118(4):647-50. doi: 10.1007/s00702-011-0615-8. Epub 2011 Feb 27.